Literature DB >> 12578234

Melbourne Assessment of Unilateral Upper Limb Function: construct validity and correlation with the Pediatric Evaluation of Disability Inventory.

Helen Bourke-Taylor1.   

Abstract

The Melbourne Assessment of Unilateral Upper Limb Function (Melbourne Assessment) is an evaluation tool that objectively measures upper-extremity function in children with cerebral palsy (CP). This study investigates how well performance on the Melbourne Assessment relates to the child's actual performance in functional tasks. Eighteen children with CP (5 to 14 years of age; nine males, nine females) were assessed using the Melbourne Assessment and the Pediatric Evaluation of Disability Inventory (PEDI). Five children had spastic quadriplegia, eight had spastic diplegia, two had spastic hemiplegia and diplegia, two had athetosis, and one had hypotonic quadriplegia with mobile ventilator dependence. Children's performances were statistically correlated using Spearman's rho to establish the relation between these tools. Very high correlation coefficients were calculated between the Melbourne Assessment and self-care (0.939) and mobility domains (0.783) of the PEDI and the overall functional skills section of the PEDI (0.718). The Melbourne Assessment demonstrates excellent construct validity for upper limb functioning.

Entities:  

Mesh:

Year:  2003        PMID: 12578234

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  27 in total

Review 1.  Assessment tools and classification systems used for the upper extremity in children with cerebral palsy.

Authors:  Lisa V Wagner; Jon R Davids
Journal:  Clin Orthop Relat Res       Date:  2012-05       Impact factor: 4.176

2.  Long term functional outcomes after early childhood pollicization.

Authors:  Nina Lightdale-Miric; Nicole M Mueske; Emily L Lawrence; Jennifer Loiselle; Jamie Berggren; Sudarshan Dayanidhi; Milan Stevanovic; Francisco J Valero-Cuevas; Tishya A L Wren
Journal:  J Hand Ther       Date:  2014-12-04       Impact factor: 1.950

Review 3.  Botulinum toxin for cerebral palsy; where are we now?

Authors:  R E Morton; J Hankinson; J Nicholson
Journal:  Arch Dis Child       Date:  2004-12       Impact factor: 3.791

Review 4.  Clinical assessment of the infant and child following perinatal brachial plexus injury.

Authors:  Susan V Duff; Carol DeMatteo
Journal:  J Hand Ther       Date:  2015-01-16       Impact factor: 1.950

5.  Spectroscopic biomarkers of motor cortex developmental plasticity in hemiparetic children after perinatal stroke.

Authors:  Helen L Carlson; Frank P MacMaster; Ashley D Harris; Adam Kirton
Journal:  Hum Brain Mapp       Date:  2016-11-17       Impact factor: 5.038

6.  Upper limb motion analysis in children with hemiplegic cerebral palsy: proximal kinematic changes after distal botulinum toxin or surgical treatments.

Authors:  Frank Fitoussi; Amadou Diop; Nathalie Maurel; El Mostefa Laasel; Brice Ilharreborde; Georges François Penneçot
Journal:  J Child Orthop       Date:  2011-09-03       Impact factor: 1.548

7.  Motor cortical functional geometry in cerebral palsy and its relationship to disability.

Authors:  T M Kesar; L Sawaki; J H Burdette; M N Cabrera; K Kolaski; B P Smith; T M O'Shea; L A Koman; G F Wittenberg
Journal:  Clin Neurophysiol       Date:  2011-12-06       Impact factor: 3.708

8.  Physical training in boys with Duchenne Muscular Dystrophy: the protocol of the No Use is Disuse study.

Authors:  Merel Jansen; Imelda Jm de Groot; Nens van Alfen; Alexander Ch Geurts
Journal:  BMC Pediatr       Date:  2010-08-06       Impact factor: 2.125

9.  SHUEE on the evaluation of upper limb in cerebral palsy.

Authors:  Ana Paula Tedesco; Renata D'Agostini Nicolini-Panisson; Aline de Jesus
Journal:  Acta Ortop Bras       Date:  2015 Jul-Aug       Impact factor: 0.513

10.  INCITE: A randomised trial comparing constraint induced movement therapy and bimanual training in children with congenital hemiplegia.

Authors:  Roslyn Boyd; Leanne Sakzewski; Jenny Ziviani; David F Abbott; Radwa Badawy; Rose Gilmore; Kerry Provan; Jacques-Donald Tournier; Richard A L Macdonell; Graeme D Jackson
Journal:  BMC Neurol       Date:  2010-01-12       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.